Health Relmada Therapeutics Stock Rises on Promising Cancer Trial Results Shares of Relmada Therapeutics Inc. (NASDAQ: RLMD) surged in premarket trading on March 6, 2023, following the announcement of positive interim results from its... Editorial9 March, 2026